￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

Oncology

Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
The emergence of the targeted drug entrectinib gives lung cancer patients an additional option

2025-10-19 11:44:20

Check Details
The effect of entrectinib in the treatment of ROS1-positive non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Application of rubitidine in small cell lung cancer

2025-10-19 11:44:20

Check Details
New chemotherapy drug for small cell lung cancer: rubitidine

2025-10-19 11:44:20

Check Details
Is rupitidine included in the national medical insurance in China?

2025-10-19 11:44:20

Check Details
Can entrectinib be used to treat small cell lung cancer?

2025-10-19 11:44:20

Check Details
Where can the targeted drug entrectinib be purchased?

2025-10-19 11:44:20

Check Details
Can capmatinib be reimbursed by medical insurance?

2025-10-19 11:44:20

Check Details
New broad-spectrum anti-cancer drug approved by FDA: Entrectinib_Cornhule

2025-10-19 11:44:20

Check Details
How much does a box of the anti-cancer drug Entrectinib cost? Where to buy it?

2025-10-19 11:44:20

Check Details
Capmatinib is suitable for the treatment of adult patients with MET-mutated non-small cell lung cancer (NSCLC)_ Kanghule

2025-10-19 11:44:20

Check Details
Can entrectinib be used in ROS1 mutated lung cancer?

2025-10-19 11:44:20

Check Details
Category
相关知识